Microbot Medical Inc.
MBOTFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Microbot Medical Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 17 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Apr 3, 2026.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2020-10-19 | Bornstein Yoseph · Director | Common Stock | S — Open market or private sale | −4,881 | 7.94 | SEC filing |
| 2020-10-12 (amended) | Bornstein Yoseph · Director | Common Stock | S — Open market or private sale | −20,000 | 7.84 | SEC filing |
| 2020-10-05 | Bornstein Yoseph · Director | Common Stock | S — Open market or private sale | −20,000 | 7.84 | SEC filing |
| 2020-10-05 | Bornstein Yoseph · Director | Common Stock | S — Open market or private sale | −14,881 | 7.74 | SEC filing |
| 2020-10-05 | Bornstein Yoseph · Director | Common Stock | S — Open market or private sale | −5,119 | 7.74 | SEC filing |
| 2020-08-17 | Bornstein Yoseph · Director | Common Stock | S — Open market or private sale | −15,000 | 10.18 | SEC filing |
| 2020-08-17 | Bornstein Yoseph · Director | Common Stock | S — Open market or private sale | −119 | 11.91 | SEC filing |
| 2019-12-23 | Gadot Harel · Chairman, President and CEO | Common Stock, par value $0.01 per share | S — Open market or private sale | −40,000 | 10.00 | SEC filing |
Showing 8 of 19 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-04-01 | Stockburger Aileen Ptucha · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +10,000 | SEC filing |
| 2026-04-01 | Wenderow Tal Baruch · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +10,000 | SEC filing |
| 2026-04-01 | Laxminarain Prattipati · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +10,000 | SEC filing |
| 2026-04-01 | Madden Martin J. · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +10,000 | SEC filing |
| 2026-04-01 | Wilson David James · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +10,000 | SEC filing |
| 2026-04-01 | Burell Scott R · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +10,000 | SEC filing |
| 2026-02-18 | Sharon Simon · General Manager, CTO | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +105,000 | SEC filing |
| 2026-02-18 | Vaknin Rachel · Chief Financial Officer | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +105,000 | SEC filing |
Showing 8 of 20 rows
Other activity
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2016-11-28 | ALPHA CAPITAL ANSTALT · 10% owner | Common Stock | J — Other acquisition or disposition | −7,977,092 | SEC filing |
| 2016-11-28 | ALPHA CAPITAL ANSTALT · 10% owner | Common Stock | J — Other acquisition or disposition | +9,753,549 | SEC filing |
| 2016-11-28 | ALPHA CAPITAL ANSTALT · 10% owner | Convertible Debenture | J — Other acquisition or disposition | +1,776,457 | SEC filing |
Showing 3 of 3 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.